Literature DB >> 7416747

Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal failure.

G R Aronoff, J J Szwed, R L Nelson, E L Marcus, S A Kleit.   

Abstract

Hypoxanthine arabinoside pharmacokinetics were measured during an adenine arabinoside continuous intravenous infusion and during hemodialysis in a patient with renal failure. Therapeutic guidelines for adenine arabinoside in renal failure are provided based on an elimination half-life of 4.7 h and a plasma clearance of 87.9 ml/min for the hypoxanthine metabolite.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7416747      PMCID： PMC283968          DOI： 10.1128/AAC.18.1.212

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Antimicrobial dosage in renal failure: a unifying nomogram.

Authors:  C S Bryan; W J Stone
Journal:  Clin Nephrol       Date:  1977-02       Impact factor: 0.975

3.  Inappropriate antidiuretic hormone following adenine arabinoside administration.

Authors:  E Ramos; R F Timmons; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

4.  Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.

Authors:  R J Whitley; S J Soong; R Dolin; G J Galasso; L T Ch'ien; C A Alford
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245
  4 in total
  5 in total

Review 1.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

2.  High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine.

Authors:  W P McCann; L M Hall; W Siler; N Barton; R J Whitley
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 3.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 4.  Comparative pharmacokinetics of antiviral nucleoside analogues.

Authors:  G D Morse; M J Shelton; A M O'Donnell
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 5.  Antiviral agents.

Authors:  E D Reines; P A Gross
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.